business

Goldman Sachs lowers Regenxbio stock price target on regulatory uncertainty

Investing.com · May 15, 2026, 9:43 AM · Also reported by 1 other source

Read full story on Investing.com → More top stories

Also covered by

MarketWatch The stock market surge has delivered a rare signal. Here’s what history suggests happens next, says Goldman Sachs

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop

Goldman Sachs lowers Regenxbio stock price target on regulatory uncertainty

Also covered by

More in business